Published in Healthcare Mergers, Acquisitions and Ventures Week, January 14th, 2006
The company expects the sale of these shares by the selling stockholders to the underwriters to be completed on December 14, 2005, subject to customary closing conditions. The company will not receive any proceeds from the offering.
In addition, the selling stockholders have granted the underwriters an option to purchase up to an additional 849,112 shares to cover over-allotments, if any. The company will not receive any proceeds from the transaction.
Merrill Lynch & Co. and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.